S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
NASDAQ:FTRP

Field Trip Health - FTRP Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$5.73
$6.06
50-Day Range
$0.84
$5.75
52-Week Range
$0.71
$6.41
Volume
64,742 shs
Average Volume
214,681 shs
Market Capitalization
$334.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$88.75

Field Trip Health MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,444.6% Upside
$88.75 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.50) to ($0.58) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.31 out of 5 stars

Medical Sector

1038th out of 1,072 stocks

Health Services Industry

12th out of 12 stocks

FTRP stock logo

About Field Trip Health (NASDAQ:FTRP) Stock

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.

Receive FTRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Field Trip Health and its competitors with MarketBeat's FREE daily newsletter.

FTRP Stock News Headlines

IIROC Trading Halt - FTRP.WT
Field Trip Health Ltd (FTRP)
See More Headlines

Receive FTRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Field Trip Health and its competitors with MarketBeat's FREE daily newsletter.

FTRP Company Calendar

Last Earnings
11/15/2021
Today
10/06/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:FTRP
Employees
104
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$88.75
High Stock Price Forecast
$125.00
Low Stock Price Forecast
$52.50
Forecasted Upside/Downside
+1,444.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-43,630,000.00
Net Margins
-1,125.12%
Pretax Margin
-1,125.43%

Debt

Sales & Book Value

Annual Sales
$3.88 million
Book Value
$0.92 per share

Miscellaneous

Free Float
N/A
Market Cap
$334.50 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Ronan Levy (Age 42)
    Co-Founder & Exec. Chairman
  • Mr. Joseph del Moral (Age 43)
    Co-Founder, CEO & Director
  • Mr. Hannan Fleiman (Age 41)
    CO-Founder, Pres & Director
  • Mr. Mujeeb Jafferi (Age 38)
    CO-Founder & COO
  • Dr. Ryan D. Yermus (Age 40)
    Co-Founder & Chief Clinical Officer
  • Ms. Donna K. Wong (Age 55)
    Chief Financial Officer
  • Mr. Matt Emmer
    Director of Operations & Bus. Devel.
  • Mr. Amardeep Manhas (Age 38)
    Chief Technology Officer
  • Dr. Nathan Bryson B.Sc. (Age 58)
    Ph.D., Chief Scientific Officer
  • Ms. Paula Amy Hewitt (Age 49)
    VP, Gen. Counsel & Corp. Sec.













FTRP Stock - Frequently Asked Questions

Should I buy or sell Field Trip Health stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Field Trip Health in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" FTRP shares.
View FTRP analyst ratings
or view top-rated stocks.

What is Field Trip Health's stock price forecast for 2022?

2 analysts have issued 12-month price objectives for Field Trip Health's shares. Their FTRP share price forecasts range from $52.50 to $125.00. On average, they predict the company's share price to reach $88.75 in the next twelve months. This suggests a possible upside of 1,444.6% from the stock's current price.
View analysts price targets for FTRP
or view top-rated stocks among Wall Street analysts.

How were Field Trip Health's earnings last quarter?

Field Trip Health Ltd. (NASDAQ:FTRP) posted its quarterly earnings results on Monday, November, 15th. The company reported ($0.90) EPS for the quarter, missing the consensus estimate of ($0.75) by $0.15. The company had revenue of $0.72 million for the quarter, compared to analysts' expectations of $1.10 million. Field Trip Health had a negative net margin of 1,125.12% and a negative trailing twelve-month return on equity of 62.71%.

When did Field Trip Health's stock split?

Shares of Field Trip Health reverse split before market open on Wednesday, August 17th 2022. The 1-5 reverse split was announced on Wednesday, August 17th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, August 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

What is Field Trip Health's stock symbol?

Field Trip Health trades on the NASDAQ under the ticker symbol "FTRP."

What is Field Trip Health's stock price today?

One share of FTRP stock can currently be purchased for approximately $5.75.

How much money does Field Trip Health make?

Field Trip Health (NASDAQ:FTRP) has a market capitalization of $334.50 million and generates $3.88 million in revenue each year. The company earns $-43,630,000.00 in net income (profit) each year or ($0.77) on an earnings per share basis.

How many employees does Field Trip Health have?

The company employs 104 workers across the globe.

How can I contact Field Trip Health?

The official website for the company is www.fieldtriphealth.com. The company can be reached via phone at 833 222 0084, via email at investors@fieldtriphealth.com, or via fax at 1-855-933-1211.

This page (NASDAQ:FTRP) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.